Article
Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System.
Cancer research - 1 Sept 2020
Tubeuf Hélène, Caputo Sandrine M, Sullivan Teresa, Rondeaux Julie, Krieger Sophie, Caux-Moncoutier Virginie, Hauchard Julie, Castelain Gaia, Fiévet Alice, Meulemans Laëtitia, Révillion Françoise, Léoné Mélanie, Boutry-Kryza Nadia, Delnatte Capucine, Guillaud-Bataille Marine, Cleveland Linda, Reid Susan, Southon Eileen, Soukarieh Omar, Drouet Aurélie, Di Giacomo Daniela, Vezain Myriam, Bonnet-Dorion Françoise, Bourdon Violaine, Larbre Hélène, Muller Danièle, Pujol Pascal, Vaz Fátima, Audebert-Bellanger Séverine, Colas Chrystelle, Venat-Bouvet Laurence, Solano Angela R, Stoppa-Lyonnet Dominique, Houdayer Claude, Frebourg Thierry, Gaildrat Pascaline, Sharan Shyam K, Martins Alexandra
Abstract excerpt
BRCA2 is a clinically actionable gene implicated in breast and ovarian cancer predisposition that has become a high priority target for improving the classification of variants of unknown significance (VUS). Among all BRCA2 VUS, those causing partial/leaky splicing defects are the most challenging to classify because the minimal level of full-length (FL) transcripts required for normal function remains to be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
